Caption Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1040 |
|
|
2025
Q1 | – | Sell |
-56,760
| Closed | -$1.09M | – | 1111 |
|
|
2024
Q4 | $1.09M | Buy |
+56,760
| New | +$1.09M | 0.01% | 197 |
|
|
2024
Q3 | – | Sell |
-44,300
| Closed | -$576K | – | 872 |
|
|
2024
Q2 | $576K | Buy |
44,300
+19,300
| +77% | +$251K | 0.01% | 195 |
|
|
2024
Q1 | $438K | Buy |
+25,000
| New | +$438K | 0.01% | 223 |
|
|
2023
Q3 | – | Sell |
-36,000
| Closed | -$856K | – | 809 |
|
|
2023
Q2 | $856K | Buy |
36,000
+21,000
| +140% | +$500K | 0.02% | 137 |
|
|
2023
Q1 | $382K | Buy |
+15,000
| New | +$382K | 0.01% | 199 |
|
|
2022
Q3 | – | Sell |
-17,777
| Closed | -$206K | – | 910 |
|
|
2022
Q2 | $206K | Buy |
+17,777
| New | +$206K | ﹤0.01% | 357 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1007 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 970 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 945 |
|